New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
This Week on NeurologyLive® — July 22, 2024
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
NeurologyLive® Friday 5 — July 19, 2024
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the Second Half of 2024